Victor Kouassi – Page 3 – REVIVE

About Victor Kouassi

This author has not yet filled in any details.
So far Victor Kouassi has created 155 blog entries.

<br>Global antibiotic use patterns in children</br><em> – by Julia A. Bielicki and Victor Musiime</em> — 27 April 2022
Global antibiotic use patterns in children – by Julia A. Bielicki and Victor Musiime
more

21 February 2022

Antimicrobial Chemotherapy Conference 2022

more

<br>The non-profit future of antibacterial R&D</br><em> – by Brad Spellberg</em> — 28 January 2022
The non-profit future of antibacterial R&D – by Brad Spellberg
more

Antibiotic Bootcamps for Developers: What Makes a Good Project Succeed? (ASM/ESCMID 2021) — 14 January 2022
Antibiotic Bootcamps for Developers: What Makes a Good Project Succeed? (ASM/ESCMID 2021)
more

New technologies and strategies to overcome the challenges of sexually transmitted infections — 21 December 2021
New technologies and strategies to overcome the challenges of sexually transmitted infections
more

<br>One-health approach: Can antifungal resistance arise in the environment?</br><em> – by Rafael W. Bastos and Gustavo H. Goldman</em> — 23 November 2021
One-health approach: Can antifungal resistance arise in the environment? – by Rafael W. Bastos and Gustavo H. Goldman
more

The roles of different actors in developing new treatments for drug-resistant infections — 1 November 2021
The roles of different actors in developing new treatments for drug-resistant infections
more

Biofilms: What are they and why do we care? — 27 September 2021
Biofilms: What are they and why do we care?
more

<br>Addressing antimicrobial resistance for better care in cancer patients</br><em> – by Yehoda M. Martei and Shalini J. Zürn</em> — 24 September 2021
Addressing antimicrobial resistance for better care in cancer patients – by Yehoda M. Martei and Shalini J. Zürn
more

<br>Trials of COVID-19 vaccines: what can be learnt for the development of new antimicrobials?</br><em> – by Stephen Senn</em> — 13 August 2021
Trials of COVID-19 vaccines: what can be learnt for the development of new antimicrobials? – by Stephen Senn
more